Next Article in Journal
Safety and Efficacy of PDpoetin for Management of Anemia in Patients with End Stage Renal Disease on Maintenance Hemodialysis: Results from a Phase IV Clinical Trial
Previous Article in Journal
Multiparameter Flow Cytometry to Detect Hematogones and to Assess B-Lymphocyte Clonality in Bone Marrow Samples from Patients with Non-Hodgkin Lymphomas
 
 
Hematology Reports is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Decreased Threshold of Aggregation to Low-Dose Epinephrine is Evidence of Platelet Hyperaggregability in Patients with Thrombosis

Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, 8700 Beverly Blvd., Los Angeles, CA 90048, USA
*
Author to whom correspondence should be addressed.
Hematol. Rep. 2014, 6(3), 5326; https://doi.org/10.4081/hr.2014.5326
Submission received: 27 January 2014 / Revised: 13 June 2014 / Accepted: 1 August 2014 / Published: 26 August 2014

Abstract

Sticky platelet syndrome has been described as a hereditary thrombophilic condition. The aim of this study is to identify the presence of platelet hyperaggregability in patients who have experienced thrombosis. Light-transmittance platelet aggregometry was used to assess for spontaneous platelet aggregation, aggregation in response to full and low-dose (LD) epinephrine (Epi) and adenosine diphosphate, as well as arachidonic acid, and identify a distinct pattern of platelet hyperaggregability. Light-transmittance platelet aggregometry results were correlated with PFA-100® (Dade-Behring, Marburg, Germany) results, when available. An exaggerated response to LD Epi was found in 68% of patients with thrombosis compared to only 36% of healthy controls (p = 0.034). Patients with thrombosis, either arterial or venous, demonstrated an exaggerated response to LD Epi nearly twice as frequently as healthy controls, even without significant family history of thrombophilia or other known risk factors for thrombosis. This suggests that platelet hyperaggregability may be multifactorial in nature and not necessarily hereditary.
Keywords: light-transmittance platelet aggregometry; hyperaggregable platelets; thrombosis; sticky platelet syndrome light-transmittance platelet aggregometry; hyperaggregable platelets; thrombosis; sticky platelet syndrome

Share and Cite

MDPI and ACS Style

Hayes, C.; Kitahara, S.; Tcherniantchouk, O. Decreased Threshold of Aggregation to Low-Dose Epinephrine is Evidence of Platelet Hyperaggregability in Patients with Thrombosis. Hematol. Rep. 2014, 6, 5326. https://doi.org/10.4081/hr.2014.5326

AMA Style

Hayes C, Kitahara S, Tcherniantchouk O. Decreased Threshold of Aggregation to Low-Dose Epinephrine is Evidence of Platelet Hyperaggregability in Patients with Thrombosis. Hematology Reports. 2014; 6(3):5326. https://doi.org/10.4081/hr.2014.5326

Chicago/Turabian Style

Hayes, Chelsea, Sumire Kitahara, and Oxana Tcherniantchouk. 2014. "Decreased Threshold of Aggregation to Low-Dose Epinephrine is Evidence of Platelet Hyperaggregability in Patients with Thrombosis" Hematology Reports 6, no. 3: 5326. https://doi.org/10.4081/hr.2014.5326

APA Style

Hayes, C., Kitahara, S., & Tcherniantchouk, O. (2014). Decreased Threshold of Aggregation to Low-Dose Epinephrine is Evidence of Platelet Hyperaggregability in Patients with Thrombosis. Hematology Reports, 6(3), 5326. https://doi.org/10.4081/hr.2014.5326

Article Metrics

Back to TopTop